Age-Related differences in immunological responses to SARS-CoV-2

Further Publications Dermatology

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Nature

Collier DA, Ferreira IATM, Kotagiri P, Datir R, Lim E, Touizer E, Meng B, Abdullahi A, CITIID-NIHR BioResource COVID-19 Collaboration., Elmer A, Kingston N, Graves B, Le Gresley E, Caputo D, Bergamaschi L, Smith KGC, Bradley JR, Ceron-Gutierrez L, Cortes-Acevedo P, Barcenas-Morales G, Linterman MA, McCoy L, Davis C, Thomson E, Lyons PA, McKinney E, Doffinger R, Wills M, Gupta RK

doi: 10.1038/s41586-021-03739-1

Further Publications Immunology

BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

Ann Rheum Dis

Moyon Q, Sterlin D, Miyara M, Anna F, Mathian A, Lhote R, Ghillani-Dalbin P, Breillat P, Mudumba S, de Alba S, Cohen-Aubart F, Haroche J, Pha M, Boutin THD, Chaieb H, Flores PM, Charneau P, Gorochov G, Amoura Z

doi: 10.1136/annrheumdis-2021-221097

Immune Response

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Nature

Lucas C, Vogels CBF, Yildirim I, Rothman JE, Lu P, Monteiro V, Gelhausen JR, Campbell M, Silva J, Tabachikova A, Peña-Hernandez MA, Muenker MC, Breban MI, Fauver JR, Mohanty S, Huang J, Yale SARS-CoV-2 Genomic Surveillance Initiative., Shaw AC, Ko AI, Omer SB, Grubaugh ND, Iwasaki A

doi: 10.1038/s41586-021-04085-y

Further Publications Immunology

Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study

J Clin Immunol

Goudouris ES, Pinto-Mariz F, Mendonça LO, Aranda CS, Guimarães RR, Kokron C, Barros MT, Anísio F, Alonso MLO, Marcelino F, Valle SOR, Junior SD, Barreto IDP, Ferreira JFS, Roxo-Junior P, do Rego Silva AM, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Di Gesu RSW, Schidlowski L, Fillipo P, Bichuetti-Silva DC, Soldateli G, Ferraroni NR, de Oliveira Dantas E, Pestana S, Mansour E, Ulaf RG, Prando C, Condino-Neto A, Grumach AS

doi: 10.1007/s10875-021-01066-8

Immune Response

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

NPJ Vaccines

Bos R, Rutten L, van der Lubbe JEM, Bakkers MJG, Hardenberg G, Wegmann F, Zuijdgeest D, de Wilde AH, Koornneef A, Verwilligen A, van Manen D, Kwaks T, Vogels R, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, Li Z, Barouch DH, Vellinga J, Langedijk JPM, Zahn RC, Custers J, Schuitemaker H

doi: 10.1038/s41541-020-00243-x

Immune Response

Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak

Pediatr Allergy Immunol.

Brandstetter S, Roth S, Harner S, Buntrock-Döpke H, Toncheva A, Borchers N, Gruber R, Ambrosch A, Kabesch M

doi: 10.1111/pai.13278.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

J Eur Acad Dermatol Venereol.

Di Altobrando A, Patrizi A, Bardazzi F

doi: 10.1111/jdv.16491.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Ann Rheum Dis.

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I

doi: 10.1136/annrheumdis-2020-217960.

Further Publications Immunology

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

N Engl J Med

El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J, COVE Study Group.

doi: 10.1056/NEJMoa2113017

Related content

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase